SCIENTIFIC MEASUREMENT SYSTEMS INC/TX
10KSB40/A, 1995-09-22
MEASURING & CONTROLLING DEVICES, NEC
Previous: RALSTON PURINA CO, SC 13D/A, 1995-09-22
Next: SEMICON INC, 10-K, 1995-09-22









          As filed with the Securities and Exchange Commission on September
          22, 1995.

                               Washington, D.C.  20549

                                 FORM 10-KSB/A No. 1

          (Mark One)
          [x]  Annual  Report  Pursuant to  Section  13  or  15(d)  of  the
               Securities Exchange  Act of 1934  for the fiscal  year ended
               July 31, 1994
                                          OR

          [  ] Transition Report  Pursuant to  Section 13  or 15(d)  of the
               Securities Exchange Act of 1934

                             Commission File No. 0-14100

                         SCIENTIFIC MEASUREMENT SYSTEMS, INC.
                    (Name of small business issuer in its charter)

                        Texas                         74-2048763
           (State or other jurisdiction of         (I.R.S. Employer
           incorporation or organization)        Identification No.)

            2210 Denton Drive, Suite 106                78758
                    Austin, Texas                     (Zip Code)
      (Address of principal executive offices)

                    Registrant's telephone number:  (512) 837-4712

          Securities registered pursuant to Section 12(b) of the Act:  NONE

             Securities Registered Pursuant to Section 12(g) of the Act:
                       Common Stock, par value $0.05 per share
                                   (Title of class)

                                                                   



             Check whether the issuer (1) filed  all reports required to  be
          filed by  Section 13  or 15(d)  of the  Exchange  Act during  the
          preceding  12  months  (or  for  such  shorter  period  that  the
          registrant was required to  file such reports), and (2)  has been
          subject to such filing requirements for the past 90 days.
                       Yes    X    or No        

             Check if there is no disclosure  of delinquent filers  pursuant
          to Item  405 of  Regulation S-B  contained in  this form,  and no
          disclosure  will  be  contained,  to  the  best  of  Registrant's
          knowledge,   in  definitive   proxy  or   information  statements
          incorporated  by reference in Part III of this Form 10-KSB or any
          amendment to this Form 10-KSB.  [X]
<PAGE>







             Scientific Measurement Systems, Inc. ("Company") hereby  amends
          its Annual Report on  Form 10-KSB for the fiscal year  ended July
          31, 1994 with respect to the Items set forth below.   The changes
          in  each case reflect certain corrections or omissions.  The only
          change  relative to Item 7. Financial Statements is to expand the
          discussion in footnote 1; to correct an error in a date set forth
          in that  footnote; and  to refer  in the  date  of the  auditor's
          report to the date of the Subsequent Events footnote.


          ITEM 7.   FINANCIAL STATEMENTS

                            INDEX TO FINANCIAL STATEMENTS
                                                                       Page

          Report of Independent Accountants . . . . . . . . . . . . . . . 3

          Financial Statements:

             Balance Sheet, July 31, 1994   . . . . . . . . . . . . . . . 4

             Statement of Income, Years Ended July 31, 1994 and 1993  . . 5

             Statement of Changes in Stockholders' Equity, Years Ended  July
          31, 1994 and 19 . . . . . . . . . . . . . . . . . . . . . . . . 6

             Statement of Cash Flows, Years Ended July 31, 1994 and 1993  7

             Notes to Financial Statements  . . . . . . . . . . . . . . . 8

          ITEM 9.   DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND  . . .  16
                    CONTROL PERSONS; COMPLIANCE WITH SECTION 16(a)
                    OF THE EXCHANGE ACT

          ITEM 10.  EXECUTIVE COMPENSATION  . . . . . . . . . . . . . .  20




















                                          2
<PAGE>






<TABLE>
<CAPTION>
                         SCIENTIFIC MEASUREMENT SYSTEMS, INC.
                     Statement of Changes in Stockholders' Equity
                          Years Ended July 31, 1994 and 1993


                                     Common stock


                                Shares       Amount     Additional
                                                        Paid-In
                                                        Capital      Accumulated
                                                                     Deficit
                                                                                    Total
     <S>                        <C>          <C>        <C>          <C>            <C>
     Balance, July 31, 1992     12,880,355   $644,018   $8,307,199   $(8,042,617)   $908,600

     Issuance of unregistered
       common stock for
       services rendered        150,000      7,500      9,000        -              16,500

     Net loss                   -            -          -            (362,808)      (362,808)
     Balance, July 31, 1993     13,030,355   651,518    8,316,199    (8,405,425)    562,292

     Net loss                   -            -          -            (81,373)       (81,373)

     Balance, July 31, 1994     13,030,355   $651,518   $8,316,199   $(8,486,379)   $480,919
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
                                 SCIENTIFIC MEASUREMENT SYSTEMS, INC.
                                          Statement of Income
                                  Years Ended July 31, 1994 and 1993
                                                                         1994            1993
    Contract revenues:
      <S>                                                           <C>             <C>
      Tomographic system sales  . . . . . . . . . . . . . . . . .   $     498,156   $     830,916 

      Research and development  . . . . . . . . . . . . . . . . .              -            6,440 
      Scanning services . . . . . . . . . . . . . . . . . . . . .         203,628         493,524 
      Field services and upgrades . . . . . . . . . . . . . . . .         882,750         505,082 
               Total revenues . . . . . . . . . . . . . . . . . .       1,584,534       1,835,962 

    Contract costs  . . . . . . . . . . . . . . . . . . . . . . .         925,792       1,051,641 


    Gross profit  . . . . . . . . . . . . . . . . . . . . . . . .         658,742         784,321 

    Operating costs:
      Marketing . . . . . . . . . . . . . . . . . . . . . . . . .         349,445         299,236 

      Research and development  . . . . . . . . . . . . . . . . .         106,833         229,592 
      General and administrative  . . . . . . . . . . . . . . . .         462,491         573,238 
               Total operating costs  . . . . . . . . . . . . . .         918,769       1,102,066 

    Loss from operations  . . . . . . . . . . . . . . . . . . . .        (260,027)       (317,745)


    Other (income) expense:
      Interest expense  . . . . . . . . . . . . . . . . . . . . .          62,040          64,333 
      Interest and other income . . . . . . . . . . . . . . . . .        (240,694)        (19,270)
               Other - net  . . . . . . . . . . . . . . . . . . .         178,654          45,063 


    Net loss  . . . . . . . . . . . . . . . . . . . . . . . . . .   $     (81,373)  $    (362,808)

    Weighted average shares outstanding . . . . . . . . . . . . .      13,030,355   1   2,967.855 

      Net loss per share  . . . . . . . . . . . . . . . . . . . .   $      (0.006)  $      (0.028)
</TABLE>
<PAGE>
<TABLE>
<CAPTION>

                                 SCIENTIFIC MEASUREMENT SYSTEMS, INC.
                                             Balance Sheet
                                             July 31, 1994
                                                Assets
    Current assets:
      <S>                                                                            <C>   
      Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . .   $      80,517 

      Trade accounts receivable, less allowance for
               doubtful accounts of $18,000 . . . . . . . . . . . . . . . . . . .          33,468 
      Costs and earned profits on long-term contracts
               in excess of related billings  . . . . . . . . . . . . . . . . . .          55,963 
      Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .          20,669 
      Prepaid expenses and other current assets . . . . . . . . . . . . . . . . .          17,930 
               Total current assets . . . . . . . . . . . . . . . . . . . . . . .         208,547 


    Property, plant and equipment, at cost  . . . . . . . . . . . . . . . . . . .       2,243,789 
      Less accumulated depreciation . . . . . . . . . . . . . . . . . . . . . . .      (1,230,205)
                                                                                        1,013,584 

    Scanning equipment, less accumulated depreciation of $110,763 . . . . . . . .         244,588 

    Other assets, less accumulated amortization of $15,191  . . . . . . . . . . .          39,596 
                                                                                    $   1,506,315 
                                 Liabilities and Stockholders' Equity
    Current liabilities:
      Accounts payable  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   $      59,290 
      Billing in excess of related costs and earned
               profits on long-term contracts . . . . . . . . . . . . . . . . . .         230,414 

      Current installments of long-term debt  . . . . . . . . . . . . . . . . . .          95,910 
      Borrowings on line of credit  . . . . . . . . . . . . . . . . . . . . . . .          30,627 
      Accrued vacation  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .          39,972 
      Accrued commissions . . . . . . . . . . . . . . . . . . . . . . . . . . . .          37,804 
      Other accrued liabilities . . . . . . . . . . . . . . . . . . . . . . . . .          25,803 

               Total current liabilities  . . . . . . . . . . . . . . . . . . . .         519,820 

    Long-term debt, less current installments . . . . . . . . . . . . . . . . . .         505,576 
               Total liabilities  . . . . . . . . . . . . . . . . . . . . . . . .       1,025,396 

    Stockholders' Equity:

      Common stock, $.05 par value; 40,000,000 shares
               authorized; 13,030,355 shares issued and outstanding . . . . . . .         651,518 
      Additional paid-in capital  . . . . . . . . . . . . . . . . . . . . . . . .       8,316,199 
      Accumulated deficit . . . . . . . . . . . . . . . . . . . . . . . . . . . .      (8,486,798)
               Total stockholder's equity . . . . . . . . . . . . . . . . . . . .         480,919 
                                                                                    $   1,506,315 

      In fiscal  1993, the  Company issued  $16,500 of  common  stock to  a consultant  in lieu  of
   payment for services rendered. 
      Cash payments for  interest were  $62,000 and $64,000  in 1994  and 1993,  respectively.   No
   taxes were paid in 1994 and 1993.
</TABLE>

<PAGE>
<TABLE>
<CAPTION>
                         Scientific Measurement Systems, Inc.
                               Statement of Cash Flows
                          Years Ended July 31, 1994 and 1993


    Operating activities:
             <S>                            <C>          <C>
             Net loss . . . . . . . . .     $(81,373)    $(362,808)

             Adjustments to reconcile net
             loss to net cash from
             operating activities:

             Depreciation and
             amortization . . . . . . .       83,827       127,803 

             Unregistered common stock
    issued for services rendered  . . .             -       16,500 

             Changes in operating assets
    and liabilities:

             Trade accounts receivable       243,688       144,748 
             Cost and earned profits on
    long-term contracts in excess of
    related billings  . . . . . . . . .       16,224       (23,334)

             Inventories  . . . . . . .       (1,676)          (74)

             Prepaid expenses and other
    current assets  . . . . . . . . . .      (13,567)       13,191 
             Billings in excess of
    related costs and earned profits on
    long-term contracts . . . . . . . .       76,057       138,832 

             Accounts payable and accrued
    expenses  . . . . . . . . . . . . .     (315,996)        7,722 

    Net cash flows from operating
    activities  . . . . . . . . . . . .        7,184        62,580 
    Investing activities:

             Capital expenditures . . .       (9,509)      (58,459)

    Net cash flows from capital
    expenditures  . . . . . . . . . . .       (9,509)      (58,459)
    Financing activities:

             Borrowings on line of credit    338,977              -

             Repayments on line of credit   (308,350)             -
             Principal payments on long-
    term debt . . . . . . . . . . . . .      (85,060)      (50,594)

    Net cash flows from financing
    activities  . . . . . . . . . . . .      (54,433)      (50,594)



                                          7
<PAGE>






    Increase in cash and cash
    equivalents . . . . . . . . . . . .      (56,758)      (46,473)


    Cash and cash equivalents at
    beginning of year . . . . . . . . .      137,275       183,748 


    Cash and cash equivalents at end of
    year  . . . . . . . . . . . . . . .    $  80,517     $ 137,275 



   Supplemental information on non-cash investing and financing activities:

     In fiscal 1993, the Company issued $16,500 of common stock to a consultant in
   lieu of payment of services rendered.
     Cash  payments  for  interest were  $62,000  and  $64,000  in  1994 and  1993
   respectively.  No taxes were paid in 1994 and 1993.
</TABLE>

          SCIENTIFIC MEASUREMENT SYSTEMS, INC.

                            Notes to Financial Statements


          1.   THE COMPANY

             Scientific Measurement  Systems,  Inc.,  ("the Company")  is  a
          research,  manufacturing and  service  company  and is  primarily
          engaged  in the  design, development,  assembly and  marketing of
          radiographic/tomographic scanning systems used for nondestructive
          examination of  the interior structure of  various materials, and
          in  providing  contract  services  with  respect  thereto.    All
          operations  of the Company are domestically based.  The Company's
          plan to address long-term cash requirements is to reduce employee
          levels  and other  operating  costs to  reflect  the reduced  and
          fluctuating levels of system  sales, system upgrades and contract
          scanning  services.  The Company is also continuing its sales and
          marketing  efforts since  successful efforts  on only one  or two
          system  sales  or  upgrades   can  have  a  significant  positive
          influence on the  Company's ability  to meet  its long-term  cash
          requirements.   The  Company,  as  funds permit,  also  seeks  to
          identify and develop new applications and uses for its technology
          in  an effort to establish a broader  and more reliable stream of
          revenue that the Company has experienced in recent years.

             During the  past four fiscal years  ended July  31, the Company
          incurred  net losses.   The  Company is  currently in  a negative
          working capital  position.  Management believes  that the Company
          has the ability to  meet its cash requirements during  the fiscal
          year  ending July  31, 1995  based on  revenues generated  by the
          Company's  current  backlog combined  with further  reductions in
          operating costs, if  necessary.   The ability of  the Company  to
          meet its long term cash requirements is dependent on any one or a
          combination of the following:  returning to profitable operations
          through  increased system  sales; securing  new sources  of cash;
          further   reducing  operating   costs   and  curtailing   company
          operations; or developing new business activities.

          2.   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

             Basis  of Accounting  - The  accompanying financial  statements
          have  been   prepared  in  accordance   with  generally  accepted
          accounting principles and assume the  Company will continue as  a
          going concern.
           
             Inventories  -  Inventories   are  stated  at  lower  of   cost
          (specific identification)  or  market and  consists primarily  of
          parts  to be  used  in the  manufacture  of tomographic  scanning
          systems.  

             Property, Plant and  Equipment - Property, plant and  equipment
          is stated at cost.   Depreciation and amortization for  financial
          statement purposes are provided  by the straight-line method over

                                          9
<PAGE>






                         SCIENTIFIC MEASUREMENT SYSTEMS, INC.

                       Notes to Financial Statements, Continued

          estimated useful lives  of two  to five years  for equipment  and
          furniture  and   fixtures  and  31.5  years   for  the  building.
          Maintenance and repairs are charged to expense as incurred.

             The major classes of property, plant  and equipment as of  July
          31, 1994 were as follows:

          Equipment . . . . . . . . . . . . . . . . . . . . . . .$1,052,335
          Furniture and fixtures  . . . . . . . . . . . . . . . .   103,259
          Building  . . . . . . . . . . . . . . . . . . . . . . .   551,788
          Land  . . . . . . . . . . . . . . . . . . . . . . . . .   536,407
             Total  . . . . . . . . . . . . . . . . . . . . . . .$2,243,789

          On  October 5, 1994, the Company sold the land and building (Note
          10).

             Scanning  Equipment -  Scanning equipment  is stated  at  cost.
          Depreciation for financial statement purposes are provided by the
          straight-line  method over estimated useful lives  of five to ten
          years.

             Patent  Rights -  The Company  holds patent  rights related  to
          procedures for tomographic examinations which are being amortized
          using the straight-line method over their remaining lives.

             Research and  Development -  Expenditures for Company-sponsored
          research and development are expensed as incurred.

          2.   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, CONTINUED

             Loss  Per  Share -  Loss per  share  is  computed based  on the
          weighted average  number of  shares outstanding during  the year.
          Stock options and warrants are not included in the computation of
          loss per share as their effect is anti-dilutive.

             Cash  and Cash Equivalents   -  For purposes  of reporting cash
          flows,  cash  and  cash  equivalents include  cash  and  interest
          bearing deposits.

             Income  Taxes -  Income taxes  are provided  based on  earnings
          reported  for financial  statement purposes.   The  provision for
          income taxes  differs from the amounts  currently payable because
          of timing  differences in the  recognition of certain  income and
          expense items for financial reporting and tax reporting purposes.


             The  Company  has  adopted  Statement  of Financial  Accounting
          Standards No. 109 "Accounting for Income Taxes" (SFAS 109) during
          fiscal  1994  and has  applied  the  provisions retroactively  to
          August 1, 1993.   The adoption of SFAS 109 changes  the Company's
          method of accounting  for income taxes  from the deferred  method

                                          10
<PAGE>






                         SCIENTIFIC MEASUREMENT SYSTEMS, INC.

                       Notes to Financial Statements, Continued

          (Accounting  Principles  Board Opinion  No.  11,  "Accounting for
          Income Taxes") to  the liability method.  Previously  the Company
          deferred  the  past tax  effects  of  timing differences  between
          financial  reporting and  taxable income.   The  liability method
          requires the  recognition of deferred tax  liabilities and assets
          for the expected future tax consequences of temporary differences
          between  tax bases  and financial  reporting bases of  assets and
          liabilities.  The adoption  of SFAS 109  did not have a  material
          effect  on  the  Company's   financial  position  or  results  of
          operations.  

             Contract Revenues -  Revenues for tomographic system sales  are
          accounted  for  under   the  percentage-of-completion  method  of
          accounting in which revenues and gross profits  are recognized as
          work is performed based on the relationship between actual  costs
          incurred and total estimated  costs at completion.  Revenues  and
          gross  profit  are  adjusted  for revisions  in  estimated  total
          contract costs and  contract value  in the  accounting period  in
          which the revisions are  made.  Estimated losses are  recorded in
          the  period such losses  are identified.   The Company recognizes
          revenue  and costs  under research  and development  and scanning
          services  contracts as  the  related services  are performed  and
          costs are  incurred.   Revenues under field  services maintenance
          contracts are  recognized on a straight-line basis  over the term
          of  the  contract;  related  costs are  expensed  when  incurred.
          Contract costs  include all direct  labor, material,  subcontract
          costs and allocations of indirect overhead.  

























                                          11
<PAGE>






                         SCIENTIFIC MEASUREMENT SYSTEMS, INC.

                       Notes to Financial Statements, Continued

          3.   LONG-TERM DEBT

             Long-term debt consists of the following mortgage notes:
             First   lien   mortgage   note   payable  to   a
             corporation due in equal monthly installments of
             $6,137 through October 2000  when the balance of
             $237,546 is due.   The monthly payments  include
             interest at a fixed rate of 10.5% per annum.  .     $457,952 



             Second  lien  mortgage note  payable  to  a bank
             which matured July 22, 1994.  . . . . . . . . .       56,615 
             Third lien mortgage  note payable to the City of
             Austin  under  its   Industrial  Expansion   and
             Retention  Loan (IERL)  Program.    The mortgage
             note is payable in equal monthly installments of
             $1,242  through  January 1997  when  the  unpaid
             balance is due.   The  monthly payments  include
             interest at a fixed rate of 3% per annum. . . .        86,919

                                                                          
                                                                  601,486 

             Less - Current installments . . . . . . . . . .              
                                                                  (95,910)
                                                                 $ 505,576


             The first lien mortgage  note is secured by  a deed of trust on
          the Company's building.  The second lien mortgage note is secured
          by  an inferior  deed of trust  on the  building and  an inferior
          vendor's lien  retained in a  warranty deed in  favor of a  bank.
          The  bank also  retains a  security interest in  certain accounts
          receivable  and  equipment.   The  third  lien mortgage  note  is
          secured by an inferior deed of trust on the building.

             On October  5, 1994,  the Company  sold its  land and  building
          (Note 10).  The  proceeds of the sale were used to  retire all of
          the Company's mortgage notes.  As of October 5, 1994, the Company
          has no long term debt.

          4.   LINE OF CREDIT

             In  October 1993,  the Company entered into  a revolving credit
          agreement with  a bank which  permits borrowings  up to  $200,000
          based  on  certain  accounts  receivable.   Interest  is  payable
          monthly  at the  bank's  prime rate  plus  1.5%.   The  agreement
          expires on October 25, 1994 at which time all borrowings are due.
          The  agreement  contains  various  covenants  which, among  other
          items, require the Company  to maintain certain financial ratios.
          At July 31, 1994, the Company was in technical default due to the
          Company's  failure  to  comply  with certain  minimum  net  worth
          requirements  under   the  agreement.    There   are  no  amounts


                                          12
<PAGE>






                         SCIENTIFIC MEASUREMENT SYSTEMS, INC.

                       Notes to Financial Statements, Continued

          outstanding under this line  as of October 21, 1994.   Management
          is  currently negotiating a  renewal of this  credit facility for
          another year.
<PAGE>


                         SCIENTIFIC MEASUREMENT SYSTEMS, INC.

                       Notes to Financial Statements, Continued

          5.   STOCKHOLDERS' EQUITY

             The  Company  has  authorized  2,000,000  shares  of  preferred
          stock,  $0.15 par  value.   As of  July 31,  1994, none  has been
          issued or is outstanding.

             The Company currently  has two existing incentive stock  option
          plans.  The first, effective August 24, 1989 ("the 1989 Plan") is
          administered  by  a Stock  Option  Committee  (the "Stock  Option
          Committee")  which consists of not less than three members of the
          Board of Directors.   The 1989 Plan reserves 2,500,000  shares of
          the  Company's  common  stock  and  provides  for  the  grant  of
          incentive stock  options, non-qualifying stock options  and stock
          appreciation  rights ("SARs")  to  certain key  employees of  the
          Company who  serve as  officers  of the  Company, to  consultants
          engaged  by  the  Company,  and  to  certain  other  individuals.
          Options and SARs will  be awarded at the discretion of  the Stock
          Option Committee.

          The 1989  Plan prohibits  the grant of  options thereunder  after
          August  24, 1999.  The Stock Option Committee also determines the
          expiration  dates of  options granted  provided that  all options
          must be exercised within 7 years of the date of grant (5 years to
          any optionee who is the owner of 10% of  the Company).  The price
          at  which options  may be  exercised is  determined by  the Stock
          Option Committee but in no  event may the price be less  than the
          fair market value  of the underlying common stock on  the date of
          grant.  In  the case of  an optionee who is  the owner of  10% or
          more  of the total combined voting  power of all classes of stock
          of the Company,  the option price  must be at  least 110% of  the
          fair value of the underlying common stock on the date of grant.

             Because  the 1989 Plan  was not  submitted for  approval of the
          shareholders within twelve months of its adoption by the Board of
          Directors,  the  options  granted  under it  do  not  qualify  as
          incentive stock  options.  It  is the intention  of the Board  of
          Directors not to award further options  under the 1989 Plan.   As
          of July 31,  1994, there  were no options  outstanding under  the
          1989 Plan. 

             On February 16, 1990, the Board  of Directors approved the 1990
          Stock Option Plan ("1990 Plan").   The 1990 Plan is  identical in
          all but one respect to the 1989 Plan.  The sole variation is that
          the 1990  Plan prohibits  the grant  of options  thereunder after
          February 16, 2000, rather than August 24, 1999.
           
             During fiscal 1993, the Board  of Directors approved  awards of
          1,003,468 options under the  1990 Plan.  During fiscal  1994, the
          Board of Directors  also approved awards of  1,959,482 options of
          which 697,623  options  were awarded  under the  1990 plan  while
          1,261,859 options  were not awarded pursuant to  any formal plan.

                                          14
<PAGE>






                         SCIENTIFIC MEASUREMENT SYSTEMS, INC.

                       Notes to Financial Statements, Continued

          All  options were  granted  at  fair  market  value  at  date  of
          issuance.  Although granted at fair market value, the majority of
          these  options   were  issued  to  directors   and  employees  in
          recognition  of significant  salary reductions  during the  year.
          Certain options vested immediately and others vest  over a period
          of  two  years.   The options  awarded in  fiscal 1993  expire on
          August  1,  1998 while  those awarded  in  fiscal 1994  expire on
          August 1, 2000.

             On  September 17,  1992,  the Board  of Directors  approved the
          issuance  of 150,000  shares of  unregistered  common stock  to a
          consultant for services rendered.   The stock was issued  at fair
          market value on the date of issuance.  The associated  expense is
          included  in general  and  administrative expenses  for the  year
          ended July 31, 1993.
<PAGE>

                         SCIENTIFIC MEASUREMENT SYSTEMS, INC.

                       Notes to Financial Statements, Continued

          5.   STOCKHOLDERS' EQUITY, CONTINUED


             The following table summarizes the status of all options.


                 OPTIONS         EXERCISE PRICE RANGE NUMBER OF SHARES
                                                        UNDER OPTION  

           Outstanding at July
           31, 1993              $.1404-$.2850              3,060,468

           Granted during FY
           1994                  $.1500                     1,959,482


           Cancelled             $.2250                       (90,000)

                                 $.1406-$.2850              4,929,950

          Options for 4,863,283 shares of common  stock were exercisable at
          July 31, 1994.  No options were exercised during fiscal 1993  and
          1994.

          6.   CONTRACT REVENUES

             The Company's  revenues have  been derived  from certain  major
             customers (greater than 10% of total revenues) as follows:
                       Customer           1994         1993


                       A                   4%          10%
                       B                  23%           -

                       C                  30%           7%

                       D                   7%          12%
                       E                   7%          15%

                       F                   -           27%















                                          16
<PAGE>






                         SCIENTIFIC MEASUREMENT SYSTEMS, INC.

                       Notes to Financial Statements, Continued

          6.   CONTRACT REVENUES, CONTINUED

             The Company had export sales of  $63,000 and $64,000 to  Japan,
          $29,000  and  $45,000 to  Canada  during  fiscal 1994  and  1993,
          respectively.  Revenues derived either  as a prime contractor  or
          subcontractor to  prime contractors  to the U.S.  Government were
          56%  and 67%  of  total revenues  during  fiscal 1994  and  1993,
          respectively.  

          Contracts in progress at  July 31, 1994 and  1993 consist of  the
          following:

<TABLE>
<CAPTION>
                                                                 1994       1993

               
               <S>                                          <C>          <C>
               Costs and estimated earnings                 $ 444,250    $493,901
               Billings                                       618,701     576,071
                                                             (174,451)   ( 82,170)
                                                                      

               Included in the balance sheet:
                  Costs and earned profits on long-term
                  contracts                                    55,963      72,187
                     in excess of related billings
                  Billings in excess of related costs and    (230,414)   (154,357)
                  earned                                     (174,451)   ( 82,170)
                     profits on long-term contracts           
</TABLE>

             Requirements  for  progress  billings   are  negotiated  on  an
          individual   contract  basis   and,  accordingly,   vary  between
          contracts.

             On December  31, 1992,  the Company collected a  settlement for
          $501,622 from the  Department of the Navy.  This  amount has been
          included in revenue from tomographic system sales in fiscal 1993.
          The settlement represents  funding of a cost  overrun incurred by
          the Company on a  cost plus fixed fee contract  begun in December
          1984  for the  design,  construction, laboratory  test and  field
          demonstration  of a remote-operated  tomographic analyzer for the
          Department of the  Navy.  Work  was stopped  on this contract  in
          fiscal year  1988 due to a  lack of funding by  the Department of
          the  Navy; no  work has  been  performed and  no costs  have been
          incurred on this contract by the Company since that time.

          7.   INCOME TAXES

             The  Company  has adopted  Statement  of  Financial  Accounting
          Standards No. 109 "Accounting for Income Taxes" (SFAS 109) during
          the fourth  quarter and has applied  the provisions retroactively
          to August 1,  1993.    The adoption of  SFAS 109  did not have  a
          material effect on the Company's financial position or results of
          operations.

                                          17
<PAGE>






                         SCIENTIFIC MEASUREMENT SYSTEMS, INC.

                       Notes to Financial Statements, Continued

             Temporary  differences  represent  the  cumulative  taxable  or
          deductible  amounts  recorded  in  the  financial  statements  in
          different  years  than  recognized  in  the  tax  returns.    The
          depreciation temporary difference  represents tax depreciation in
          excess of financial statement depreciation.  The accrued expenses
          temporary  differences represent  various  expenses  accrued  for
          financial reporting purposes until paid.













































                                          18
<PAGE>






                         SCIENTIFIC MEASUREMENT SYSTEMS, INC.

                       Notes to Financial Statements, Continued

          7.   INCOME TAXES, CONTINUED
            
             The tax-effected temporary differences  and carryforwards  that
          comprise deferred tax assets at July 31, 1994 are as follows:

                                                 Deferred
                                                Tax Asset   Deferred Tax
                                                              Liability

             Accrued expenses  . . . . . . . .$   29,767    $       - 
             Depreciation  . . . . . . . . . .        -         55,188
             Other . . . . . . . . . . . . . .      6,351           - 
               Total temporary difference  . .     36,118       55,188
             Operating loss carryforward . . . 2,830,477            _ 
             Tax credit carryforward . . . . .    144,157           - 
               Total operating loss and tax
               credits   . . . . . . . . . . . 2,974,634            - 

               Deferred tax asset  . . . . . . 3,010,752        55,188
             Valuation allowance . . . . . . .(2,955,564)           - 
             Net deferred tax assets and
             liabilities . . . . . . . . . . .$   55,188    $   55,188



             At  July   31,  1994  the  Company  had    available  financial
          reporting  net  operating  loss  carryforwards  of  approximately
          $8,400,000  and   for  federal  income  tax   reporting  purposes
          approximately  $8,300,000  of  which  $250,000  expires  in 1998,
          $480,000 expires in  1999 with  the balance  expiring in  varying
          amounts  in  2000  through  2009.    The  difference between  net
          operating loss carryforwards for financial reporting purposes and
          federal  income  tax purposes  is  due  primarily to  accelerated
          depreciation  methods  used  for  tax.   Also,  the  Company  had
          approximately $30,000 of investment  tax credit carryforwards and
          approximately  $110,000 of  research  and development  tax credit
          carryforwards expiring from 1996  to 2001.  Under the  Tax Reform
          Act of  1986, as amended, an annual  limitation will be placed on
          the amount of  net operating  loss and  tax credit  carryforwards
          which may be  utilized if  there are substantial  changes in  the
          ownership of the Company.

             SFAS 109 requires  the recording of a valuation allowance  when
          it  is "more  likely than  not that  some portion  or all  of the
          deferred tax assets  will not  be realized."   It further  states
          that "forming  a conclusion  that a  valuation  allowance is  not
          needed  is difficult  when  there is  negative  evidence such  as
          cumulative losses in recent years."   The ultimate realization of
          this deferred  income  tax  asset  depends upon  the  ability  to
          generate sufficient  taxable income in the  future.  Accordingly,
          the  Company has provided a valuation allowance at August 1, 1993
          and July 31,  1994 to the extent realization of  the deferred tax
          assets depends on taxable income in future years.  If the Company
          is  unable to  generate sufficient taxable  income in  the future

                                          19
<PAGE>






                         SCIENTIFIC MEASUREMENT SYSTEMS, INC.

                       Notes to Financial Statements, Continued

          through operating results,  increases in the valuation  allowance
          will be required.

             There were  no federal or  state income taxes  paid in  1994 or
          1993.  There were  no significant amounts of income  from foreign
          sources in 1994 or 1993.
               













































                                          20
<PAGE>






                         SCIENTIFIC MEASUREMENT SYSTEMS, INC.

                       Notes to Financial Statements, Continued

          8.   OTHER INCOME

             During  fiscal  1994,  the  Company  reversed  certain  royalty
          accruals resulting in  a charge to other  income of approximately
          $218,000.   Since 1988, the Company had accrued royalties on non-
          government CT systems sales based on a cross-licensing agreement.
          The Company has canceled this agreement and determined that there
          are no amounts payable thereunder.

          9.   RELATED PARTY TRANSACTIONS

             In  1981,  the  Company  purchased  from  various  stockholders
          certain technology  and patent  rights related to  the procedures
          for  tomographic examinations.  The  cost of such  rights, net of
          accumulated amortization,  of $7,329  and $8,100 are  included in
          other assets at July 31, 1994  and 1993.  During fiscal 1993, the
          Company reassigned  ownership of the patents  to the stockholders
          in return  for cancellation  of the Company's  royalty commitment
          and  issuance  to  the  Company of  a  perpetual,  non-exclusive,
          royalty free license to the patents.

          10.  SUBSEQUENT EVENTS

             On October 5, 1994,  the Company sold its land and building for
          $1,060,000.    Proceeds from  the sale  were  used to  retire all
          mortgage notes outstanding, in  the aggregate amount of $600,000.
          Net of all related expenses and retirement of mortgage notes, the
          Company   generated   approximately   $350,000  cash   from   the
          transaction,  while realizing a loss  of $8,000.   The Company is
          currently  leasing back  the building  for an  initial  six month
          period, at a monthly lease rate of $14,000.





















                                          21
<PAGE>






          ITEM 9.   DIRECTORS,  EXECUTIVE  OFFICERS, PROMOTERS  AND CONTROL
                    PERSONS; COMPLIANCE WITH SECTION 16(a) OF THE  EXCHANGE
                    ACT

             Each of  the following directors is elected for a period of one
          year  and  thereafter  until  their successors  are  elected  and
          qualified.  Officers are appointed by and serve at the discretion
          of the Board.

             J. Neils  Thompson, P.E.,  Chairman of  the Board,  has been  a
          director of the  Company since  March 1980, and  Chairman of  the
          Board since September 1980.  He served as President during May  -
          September  1980.    Mr. Thompson  has  been  associated with  The
          University  of Texas  at  Austin  since  1941,  and  has  been  a
          Professor  of Civil Engineering since  1949.  He  was Director of
          the Balcones Research Center  from 1946 to 1977, Director  of the
          Balcones  Institute for  Research  and Development  from 1973  to
          1977,   and  Director   of  the  Structural   Mechanics  Research
          Laboratory from 1953 to 1978.   He was President of the  National
          Society of Professional Engineers  in 1965-66.  He is  the author
          or co-author  of over two hundred  technical publications, books,
          papers and reports in the fields of concrete, structures, housing
          research,  sonic   boom  research,  materials   and  experimental
          mechanics.

             Dr.  Larry  Secrest,  President and  Chief  Executive  Officer,
          joined the Company in January 1986.  During  the period from 1982
          through 1985 he served as an advisor and consultant for strategic
          planning  and venture  management; first,  as owner of  Secrest &
          Associates  from  September  1982  through  September  1984;  and
          subsequently, as a member  of Ozark Research Group,  from October
          1984  through December  1985.   During  the  period between  1978
          through September  1982, Dr. Secrest served  in various executive
          positions with Standard Meat  Company including that of Executive
          Vice President from 1980.   He has also held positions  with Ford
          Motor Company, Lear Siegler, and Cooper Industries.   Dr. Secrest
          holds  a B.A.  from  Tulane University  and  an M.B.A.  from  the
          Wharton  School of  Business.   He received  an interdisciplinary
          Ph.D.  in  Management,  Business  and  Public  Affairs  from  The
          University  of Texas at Austin in 1971.  During 1971-72 he served
          as visiting  Fulbright Research  Professor at Keio  University in
          Tokyo, Japan.   Dr. Secrest was elected as Chairman  of the Board
          of Hydrolab Corporation in September 1994.

             Douglas  G. Chaffin served  as a  director of  the Company from
          1986 to 1988 and as an Advisory Director from 1988  to 1991, when
          he again was  elected to the Board of Directors.   Since 1988, he
          has  served   as  Associate   Vice  President  of   First  Albany
          Corporation,   a  full-service  brokerage   firm.    He  attended
          Wentworth  Institute in  Boston,  Massachusetts  and Western  New
          England  College in Springfield, Massachusetts.  Mr. Chaffin is a
          member   of  Amex   Club,  Securities   Traders  Association   of
          Connecticut,  National  Association  of Securities  Traders,  and
          Hartford Stock Brokers Association.   Additionally, he has served
          as President  of Evergreen Ventures, Inc.,  a private corporation

                                          22
<PAGE>






          active in the hospitality industry.  Mr Chaffin is also listed in
          Who's Who in the East and Who's Who in the World.

             General  Robert  J. Dixon  (USAF, Retired)  was elected  to the
          Board in September 1986.  General Dixon retired from the U.S. Air
          Force in 1978 with the rank of General.  His military assignments
          included   service  as  Commander,   Tactical  Air   Command  and
          Commander-in-Chief of  the U.S.  Air Force  for the  Atlantic and
          U.S.  Readiness  Commands  as  well  as  Deputy Chief  of  Staff,
          Personnel, for the U.S. Air Force.  He served as  Chairman of the
          Board  of Directors,  Chief  Executive Officer  and President  of
          Fairchild-Republic Company from 1978 to 1983.  Since 1983, he has
          been  engaged in consulting to the aerospace industry as owner of
          Confer  Associates, Boerne,  Texas.   He  currently  serves as  a
          director  of Burdeshaw Associates, Ltd., and a trustee of the Air
          Force Aid Society.  He is a graduate of Dartmouth College and the
          U.S. Air War College.

             Dr.  Norman Hackerman  was  elected  to the  Board in  November
          1988.   Dr. Hackerman served as President of Rice University from
          1970  to 1985  and  holds the  title  of President  Emeritus  and
          Distinguished Professor Emeritus of Chemistry at Rice University.
          Prior to  his service at  Rice, Dr. Hackerman  served twenty-five
          years at The University of  Texas at Austin, Texas, where  he was
          President 1967-70,  Vice Chancellor for Academic  Affairs 1963 to
          1967,  and Vice President and  Provost 1961-63.   He is currently
          Professor  Emeritus of Chemistry  at The  University of  Texas at
          Austin.   He  received  his A.B.  and  Ph.D. from  Johns  Hopkins
          University.  Dr. Hackerman  was a member of the  National Science
          Board 1968-80, and  Chairman 1975-80.  He  was the Editor  of the
          Journal of the Electrochemical Society from  1969 to 1990.  He is
          a member  of  the  National  Academy of  Sciences,  the  American
          Philosophical  Society,  and the  American  Academy  of Arts  and
          Sciences and belongs to numerous scientific organizations.  He is
          author  or coauthor of more than 200 publications.  Dr. Hackerman
          received the American Institute of  Chemists Gold Medal in  March
          1978, the Mirabeau  B. Lamar  Award of the  Association of  Texas
          Colleges  and Universities  in  1981,  the Distinguished  Alumnus
          Award  from Johns  Hopkins  University in  1982,  and the  Edward
          Goodrich Acheson  Award of  the Electrochemical Society  in 1984.
          Dr. Hackerman serves as Chairman of the Scientific Advisory Board
          of  the Robert  A.  Welch Foundation  and as  a  director of  the
          following companies:  American  General Series Portfolio Company,
          American  Capital  Asset  Management  Corporation,  Carbon  Fuels
          Corporation, Medical Polymers, Inc., and Electrosource, Inc.  Dr.
          Hackerman was presented the National Medal of Science award  from
          President  Clinton on September 30, 1993 for his lifetime of work
          in  scientific  research and  policy issues.    The Medal  is the
          highest award this country gives to scientists.

             Burton W. Kanter was elected to the Board  in August 1985.  Mr.
          Kanter is a  lawyer specializing in  federal income tax  matters,
          formerly attorney-advisor to the Tax  Court of the United States,
          author  of  numerous  articles  in the  field  of  federal income
          taxation and a member of the faculty of the University of Chicago

                                          23
<PAGE>






          Law School.  He was a partner in the Chicago law firm of Kanter &
          Eisenberg from May 1979 to January 1986.  Since that time, he has
          served  as counsel  to  the  successor  firm  of  Neal  Gerber  &
          Eisenberg.  He is  a Director of Logic Devices,  Inc., HealthCare
          COMPARE   Corp.,   Channel  America   LPTV  Holdings,   Inc.  and
          Power-Cell,  Inc.,  plus many  private  companies.    He is  also
          Chairman  of Walnut  Capital  Corp., a  qualified small  business
          investment corporation, and Chairman  of Chicago Holding, Inc., a
          private investment company.  Mr. Kanter  is a member of the Board
          of Directors of various other charitable organizations.

             James W. Kenney was elected to the Board in March 1986.  He  is
          currently  associated   with  San  Jacinto  Securities,  Inc.  as
          Executive Vice President and  owner.  Previously, he served  as a
          Senior Vice  President of  both Rauscher Pierce  Refsnes, Dallas,
          Texas, and  Capital Institutional Services,  Inc., Dallas, Texas,
          and  as Executive  Vice President  for a  full-service securities
          brokerage firm that was the managing underwriter  for the initial
          public offering of the Company in  March 1985.  In addition,  Mr.
          Kenney serves as a member of  the Board of Directors of Amerishop
          Corporation, Consolidated Health Care Associates, Inc., CCC Coded
          Communications  Corp.,  Industrial Holdings,  Inc.,  Prism Group,
          Inc.,  Appoint Technologies,  Tecnol  Medical Products,  Inc. and
          Tricom  Corporation.  Mr.  Kenney received a  B.B.A. in Economics
          from the University of Colorado in 1964.

             Phillips  A. Moore was  elected to  the Board  in January 1987,
          and is  currently a consultant to PRESBYNET/ECUNET,  a project to
          develop a  global telecommunication  system for churches.   Until
          June  1991, Mr.  Moore  was Chairman  of  PSN Corporation,  Avon,
          Connecticut,  a  firm  that   develops  and  sells  comprehensive
          electronic  communications systems  to industry.   Prior  to that
          position, Mr. Moore served as President of NWI, Inc., and as Vice
          President,  Product Development,  for Sony  Corporation.   He has
          extensive  experience in high  technology product development and
          marketing.

             Dr. Tom Prud'homme was elected to  the Board in November  1990.
          Dr. Prud'homme  recently became Vice President  for Technology of
          EnviroTech  Measurements  and  Controls.    Prior  to  that,  Dr.
          Prud'homme was  Vice President for  Technology of  a division  of
          Baker,  Hughes, Inc.  He  co-founded a research  company 34 years
          ago and led  the firm  through three  changes in  ownership to  a
          highly  successful  instrumentation   company.    After  teaching
          mathematics  and physics at The University of Texas at Austin, he
          was   employed  as   Research  Scientist  in   applied  nucleonic
          techniques by Magnolia  Petroleum Co.  (now Mobil Oil  Co.).   In
          1956, he  helped establish Texas Nuclear  under private ownership
          and  then  served as  Chief Scientist  and Director  of Research.
          From  1961 to 1966, Dr.  Prud'homme served as  Vice President for
          Manufacturing  and  then  Vice  President  for  Engineering   and
          Production  of the  Texas  Nuclear  Division of  Nuclear-Chicago.
          During this time, he  designed, tested, commissioned and directed
          the manufacture of a commercial atom smasher.  From 1966 to 1975,
          he served successively as  Vice President for Operations, General

                                          24
<PAGE>






          Manager, President and  CEO of the  Texas Nuclear Division,  G.D.
          Searle & Co.  From 1975  to 1987, he was President, Texas Nuclear
          Division, Baker  International, which became Baker,  Hughes, Inc.
          During  this  time, Texas  Nuclear  maintained profitability  and
          achieved  financial goals  in  each year.    In 1987,  he  became
          Chairman  of  the Board  of  Directors,  Texas Nuclear  Division,
          Baker,  Hughes,  Inc.     Dr. Prud'homme  is  the  author  of  22
          publications  and is  very active  in professional  and community
          affairs.   He  serves  on a  number of  Boards  of Directors  and
          Advisory Committees and is an officer of a family-owned business,
          Amal  Oil Company.    Dr.  Prud'homme  holds  a  B.S.  degree  in
          Physics/Mathematics from  Spring Hill College and  M.A. and Ph.D.
          degrees from The University of Texas at Austin.


                                  EXECUTIVE OFFICERS

             The following information relates to executive officers of  the
          Company who were not directors during FY 1994:


           Officer                Position with the
                                  Company                   Age     Year
                                                                   Became
                                                                   Officer


           Dr. Forrest F.
           Hopkins                Vice President of
                                  Research and Development   48     1979

           Gen. George A.
           Edwards, Jr.           Vice President of
                                  Administration,
                                  Secretary-Treasurer        65     1988



           Keith A. Jezek         Vice President of
                                  Operations                 30     1992


           H. Peter Engel         Vice President             57     1993
           Walter A. Graeme, Jr.  Vice President, Sales
                                  and Marketing              48     1994


          Background of Officers

             Forrest  F. Hopkins,  Ph.D.,  Vice President  of  Research  and
          Development,  has  been a  Director or  a  Vice President  of the
          Company since July 1979.  He chose not to stand for reelection to
          the  Board  in  1986 to  permit  the  addition  of other  outside
          participants.    Dr.  Hopkins  has extensive  experience  in  the
          development  of  tomographic  hardware  and  image reconstruction
          algorithms.  He received a B.S. in Physics in 1969 and a Ph.D. in
          Physics in 1972, both from The University of Texas at Austin.

             George A.  Edwards, Jr.  (Major General,  USAF, Retired),  Vice
          President  of Administration  and  Secretary-Treasurer, has  been
          with  the  Company  since  February   1986  serving  first  as  a
          consultant  and  aerospace advisor  and  subsequently  as Special
          Assistant to the President prior to assuming his present position
          in  February 1988.   He retired from  the U.S. Air  Force in 1984


                                          25
<PAGE>






          after a  distinguished career which included many  key high level
          staff  management and  command assignments.   Since 1984,  he has
          served  as Chairman of the  Board of Directors  of Pilot Research
          Associates,  consultant to  Lockheed Missiles and  Space Company,
          Inc.,  Associate  of Burdeshaw  Associates,  Inc.,  and has  been
          active  in  the  real  estate  and  home  construction  business.
          General Edwards attended  the University of Tennessee and holds a
          Bachelors Degree  from the University  of Maryland and  a Masters
          Degree  from  San  Francisco State  University.    He  is also  a
          distinguished graduate of the U.S. Army War College.

             Keith  A.  Jezek   joined  the  Company  as  Special   Projects
          Administrator in January 1989 and served successively as Director
          of  Budgets, Schedules, and Reports and  Director of New Business
          Development.     Mr.  Jezek   is  currently  Vice   President  of
          Operations.  He  holds a Master of Business Administration degree
          and  a  Bachelor  of  Arts  in  English  degree,  both  from  The
          University of Texas  at Austin.   Mr. Jezek came  to the  Company
          from  Dell  Computer  Corporation  where  he  worked  as  a Sales
          Analyst.

             H.  Peter Engel, Vice President, joined the Company in February
          1993.   Previous  to  joining the  Company  he was  an  assistant
          professor of Science Education and Coordinator of Adult Education
          with  the  State  University of  New  York  at Albany.    He held
          positions in  nuclear engineering and signal  processing with the
          General  Electric Company,  Knolls  Atomic  Power  Laboratory  in
          Schenectady, New  York from 1969 to 1984.   From 1984 until 1993,
          Mr.  Engel  was employed  as Chief  Scientist  with EG&G  at NASA
          Kennedy  Space  Center.   He held  a post  as  an NDEA  Fellow in
          Nuclear Engineering at  the University  of Arizona,  Tucson.   He
          holds a B.S. degree in Physics/Math and Education Philosophy from
          SUNY,  and  a M.S.  Degree  in  Natural  Science from  Rensselaer
          Polytechnic Institute, Troy, New York.  He holds U.S. patents for
          a CT System Calibrator  and Ultrasonic Transducer Holder assigned
          to  NASA  and  GE, respectively.    Mr.  Engel  resigned as  Vice
          President effective  June 14,  1994 to pursue  business interests
          near his home in Florida.   He will continue to serve the Company
          as a consultant when required.

             Walter A.  Graeme, Jr.,  Vice President,  Sales and  Marketing,
          joined the Company  in March 1994.  Prior to  joining the Company
          he  was  employed by  the Dupont  Company  for 22  years, serving
          successively   as   Technical  Representative,   Territory  Sales
          Manager, Senior Business Analyst, Product Manager, Nondestructive
          Testing  (NDT)  Systems  and  Business  Manager,  NDT  Electronic
          Imaging.  From  1968 to 1972, he held a  position with AETNA Life
          and Casualty Co.  Mr.  Graeme holds a Bachelor of Arts  degree in
          Economics  from  St. Francis  College and  an M.B.A.  from Sacred
          Heart  University in Connecticut.   Since 1992, he  has served as
          Director of  the American  Society for Nondestructive  Testing, a
          position he still holds.




                                          26
<PAGE>






          Section 16(a) Disclosure

             Section  16(a) of  the Securities  Exchange  act of  1934  (the
          "Exchange  Act") requires  the Company's officers  and directors,
          and persons who own more than 10 percent of a registered class of
          the  Company's equity securities to file reports of ownership and
          changes in ownership with  the Securities and Exchange Commission
          and  the National  Association  of  Securities Dealers  Automated
          Quotation  System ("NASDAQ").    Officers, directors  and greater
          than 10 percent  stockholders are required  by SEC regulation  to
          furnish the Company with  copies of all Section 16(a)  forms they
          file.

             Based  solely  on  its  review  of  the  copies  of  such forms
          received by it, or written representations from certain reporting
          persons  that no  Forms 5  were required  from such  persons, the
          Company believes that during fiscal 1994, its officers, directors
          and greater than 10 percent  beneficial owners complied with  all
          filing  requirements  of  Section   16(a)  of  the  Exchange  Act
          applicable to them.


          ITEM 10.  EXECUTIVE COMPENSATION

             The following  table shows the  cash compensation  paid by  the
          Company, as well as certain other compensation, for the Company's
          Chief Executive Officer for fiscal years 1992, 1993 and 1994.  No
          other executive officers were paid compensation in fiscal 1994 in
          excess of $100,000.
<TABLE>
<CAPTION>
                                Summary Compensation Table
                                          Long Term Compensation
                 Annual Compensation                                             Awards    
              Name and
          Principal
         Position            Year     Salary      Bonus     Other Annual
                                                           Compensation(1)  Options/SARs
                                                                                (#)    


         Larry Secrest,
         President and
         Chief Executive
         <S>                 <C>     <C>           <C>         <C>
         Officer             1994    $             -0-         $9,013         521,607



                             1993    $             -0-         $8,478        312,964  
                             1992    $100,859      -0-         $8,183       525,000(2)
            _____________________

              (1)      Consists of  an automobile allowance of  $500 per month
                    and group hospitalization individual coverage.
              (2)      Of  the  total  option  award,  350,000  represent  new
                    replacement  options  granted  in  connection  with the
                    surrender  of  options  for  the  purchase  of  400,000
                    shares.  See "Stock Option Awards" below.

</TABLE>



                                          27
<PAGE>






             As of  approximately the  end of  fiscal year  1992, the  Chief
          Executive  Officer, together  with  certain executive  and  other
          Company personnel, agreed to a  reduction in their regular levels
          of compensation, in view of the Company's financial position. 

             Insurance Benefits

             The Company  provides partial payment of  the premiums under  a
          group  hospitalization program  with  Aetna, which  includes term
          life  insurance  for  participating  employees.    All  full-time
          employees are eligible to participate in the program.  Individual
          coverage for  Dr. Secrest is paid for by the Company, the cost of
          which  is  included   in  the  amounts   shown  in  the   Summary
          Compensation Table above.

          Executive Stock Options

             The following  table provides information  on the stock  option
          grants  during  the  1994  fiscal  year  to  the  named executive
          officers.

                      Option Grants in Last Fiscal Year Individual Grants 



<TABLE>
<CAPTION>
                     
             Name      
                          Options/SARs
                             Granted
                            (Shares)      Percentage of
                                          Total Options/
                                           SARs Granted
                                           to Employees
                                          in Fiscal 1994   Exercise
                                                          Price (Per
                                                             Share)   Expiration
                                                                          Date   


             Larry
             <S>             <C>              <C>            <C>        <C>
             Secrest         521,607          35.63%         $0.15      8/1/2000


</TABLE>
             Stock Option Awards

             Effective August 1,  1991, the Company  offered certain  of its
          officers  and  employees,  including  Chairman  Thompson ("Option
          Holders") the  opportunity to  surrender  outstanding options  in
          exchange for  a lesser number  of Replacement Options  (herein so
          called).   The Replacement Options were issued as incentive stock
          options  under   the  Company's  1990  Stock   Option  Plan;  are
          exercisable at $0.1406 per share (the average bid and ask closing
          price on August  1, 1991);  vest one-third upon  grant, and  one-
          third on  each of the next two  anniversary dates thereof; are in
          tandem with  stock appreciation rights;  and expire on  August 1,
          1998.  All  of the Option Holders, except one, accepted the offer
          in full.

             Effective March 24, 1994, the  Company granted options  for the
          purchase  of common stock to  employees who had  foregone part of
          their normal pay since  mid-year calendar 1993.  The  salary they


                                          28
<PAGE>






          had  not received  and would  not receive  through June  1994 was
          $143,948.  Ten options were granted for each dollar of salary the
          employee did not receive.   Under this formula, 1,439,480 options
          were granted.  These  options were vested immediately  (March 24,
          1994), and the exercise price was the average  of the closing bid
          and ask price ($0.15) on the date the options were granted.

             The  following  table provides  information  concerning  option
          exercises during and certain options held  at the end of the last
          fiscal year.

                          Aggregated Option/SAR Exercises in Last Fiscal Year
                                and Fiscal Year-End Option/SAR Values         





<TABLE>
<CAPTION>
               Name(a)      Shares
                          Acquired on
                          Exercise(b)      Value
                                         Realized
                                            (c)          Number of
                                                        Unexercised
                                                      Options/SARs at
                                                           FY-End
                                                        Exercisable/
                                                      Unexercisable(d)       Value of
                                                                         Unexercised In-
                                                                            the-Money
                                                                         Options/SARs at
                                                                              FY-End
                                                                           Exercisable/
                                                                         Unexercisable(e)
             Larry
             <S>               <C>          <C>        <C>                   <S><C>
             Secrest          -0-           -0-        1,359,571/-0-         -0-/-0-

</TABLE>

          Directors' Compensation

             The  Company,  until  late in  fiscal year  1992,  paid outside
          directors  $500  plus  expenses  for each  meeting  and  separate
          committee meeting attended in  person.  However, this arrangement
          was  suspended in  July  1992, subject  to  reinstatement by  the
          Board, in view of the Company's financial condition.

             In fiscal  1994, the Company  granted options  for the purchase
          of 50,000 shares of common stock to each  outside director.  This
          action  was in recognition of the fact that the outside directors
          served for  almost  two years  without any  compensation.   These
          options are at an exercise price  of $0.15, which is the  average
          of the closing bid and ask price as of March 24, 1994.

















                                          29
<PAGE>




                                      SIGNATURES


             Pursuant to the requirements  of the Securities Exchange Act of
          1934,  the Registrant has duly caused this Amendment to be signed
          on its behalf by the undersigned, thereunto duly authorized, this
          21st day of September, 1995.

                                        SCIENTIFIC   MEASUREMENT   SYSTEMS,
          INC.
                                        (Registrant)


                                        By:  /s/Larry Secrest              
                                             Dr. Larry Secrest, President


                 Signature               Title                     Date


                     *        
             J. Neils Thompson

             /s/Larry Secrest 
             Dr. Larry Secrest


                     *        
             Douglas G.
             Chaffin    

                     *        
             General Robert J.
             Dixon

                     *        
             Dr. Norman
             Hackerman

                     *        
             Burton W. Kanter

                     *        
             James W. Kenney

                     *        
             Phillips A. Moore

                              
             Dr. Thomas
             Prud'homme          Chairman of the
                            Board of Directors

                             President, Chief
                            Executive Officer,
                               Acting Chief
                              Financial and
                           Accounting Officer,
                               and Director

                                 Director


                                 Director


                                 Director


                                 Director


                                 Director


                                 Director


                                 Director       September 21, 1995


                                                September 21, 1995




                                                September 21, 1995


                                                September 21, 1995


                                                September 21, 1995


                                                September 21, 1995


                                                September 21, 1995


                                                September 21, 1995


                                                                  
                                                            



          *By: /s/Larry Secrest                   
               Dr. Larry Secrest
               Attorney-in-Fact





                                            30
<PAGE>

                 REPORT OF INDEPENDENT ACCOUNTANTS




 To the Board of Directors and Shareholders
 of Scientific Measurement Systems, Inc.

  In our opinion, the accompanying balance sheet and the related statements
 of  income,  of  changes in stockholders' equity and of cash flows present
 fairly, in all material  respects,  the  financial  position of Scientific
  Measurement  Systems,  Inc.  at  July  31, 1994, and the results  of  its
 operations and its cash flows for each of  the  two  years  in  the period
  ended  July  31,  1994  in  conformity with generally accepted accounting
 principles.  These financial statements  are  the  responsibility  of  the
 Company's management; our responsibility is to express an opinion on these
  financial  statements  based  on  our audits.  We conducted our audits of
 these statements in accordance with  generally accepted auditing standards
 which require that we plan and perform  the  audit  to  obtain  reasonable
  assurance  about  whether  the  financial statements are free of material
 misstatement.  An audit includes examining,  on  a  test  basis,  evidence
  supporting  the  amounts  and  disclosures  in  the financial statements,
 assessing the accounting principles used and significant estimates made by
  management, and evaluating the overall financial statement  presentation.
 We  believe  that  our  audits  provide a reasonable basis for the opinion
 express above.

  The  Company's  revenues  have declined  and  the  Company  has  incurred
 recurring net losses.  Additionally,  the  Company  has  a working capital
 deficit of approximately $311,000 at July 31, 1994.  Management's plans to
  mitigate the effect of these conditions are discussed in Note  1  to  the
 financial statements.


 /s/
 PRICE WATERHOUSE

 Austin, Texas
 September 16, 1994,
   except as to Notes 2, 3 and 10, which are as of October 21, 1994



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission